US$ 28.23
retatrutide pregnancy is being talked about as the next big weight loss peptide. But a Victorian Government health warning over the weekend has linked products sold as 'Retatrutide' to six cases of acute The Advertiser - A woman
Description
Exendin4 exerts osteogenic actions in insulinresistant and type 2 diabetic states
J Thorac Oncol

To overcome this limitation, the pharmaceutical industry developed GLP-1 analogs, compounds designed to mimic the hormones action while extending its duration

Now everyone is using them, seemingly, and one side effect in particular has stepped to the forefront of the conversation about GLP-1 use sudden and sometimes severe hair loss

Among more than 6,800 colon cancer patients in a 2024 study, around 16% of the 103 on a GLP-1 drug died within five years compared to 37% of those who were not taking one
